Abstract
Introduction: Despite adherence to current guidelines regarding dose adjustment and drug-level monitoring, beta-lactam-induced encephalopathy can still occur in the setting of chronic renal impairment.
Case Report: We report what we believe is the first case of piperacillin- and tazobactam-induced encephalopathy in a patient with pre-existing cefepime-induced encephalopathy in the context of end-stage kidney disease despite adequate dose adjustment for renal impairment.
References
Views: 1205
HTML downloads: 735
PDF downloads: 577
Dose Adjusted Beta Lactam Antibiotic Induced Encephalopathy in a Patient with End Stage Renal Impairment. A Case Report downloads: 0
Published:
2015-02-11
Issue:
Vol. 2 No. 1 (2015)
(view)